2019
DOI: 10.1111/anae.14705
|View full text |Cite
|
Sign up to set email alerts
|

Trial sequential analysis: adding a new dimension to meta‐analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
60
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 69 publications
(60 citation statements)
references
References 24 publications
0
60
0
Order By: Relevance
“…The Sidik Jonkman random effects model, that is less likely to underestimate the heterogeneity between trials, was chosen to calculate the Z‐statistic, which is equal to the meta‐analysed intervention effect divided by its standard error. In cumulative meta‐analysis, adjusted significance testing has two objectives: first, to measure and account for the strength of the available evidence; and second, to control for the risk of type‐1 and type‐2 statistical errors occurring when repeated significance testing on accumulating data is performed 13. The strength of the available evidence can be considered by determining the required information size for a conclusive and reliable meta‐analysis.…”
Section: Methodsmentioning
confidence: 99%
“…The Sidik Jonkman random effects model, that is less likely to underestimate the heterogeneity between trials, was chosen to calculate the Z‐statistic, which is equal to the meta‐analysed intervention effect divided by its standard error. In cumulative meta‐analysis, adjusted significance testing has two objectives: first, to measure and account for the strength of the available evidence; and second, to control for the risk of type‐1 and type‐2 statistical errors occurring when repeated significance testing on accumulating data is performed 13. The strength of the available evidence can be considered by determining the required information size for a conclusive and reliable meta‐analysis.…”
Section: Methodsmentioning
confidence: 99%
“…The risk of postoperative nausea was also reduced, with a risk ratio (95%CI) of 0.78 (0.67-0.91) (35 studies, 1903 participants).The quality of evidence was very low for most of these outcomes, however, and ultimately the authors concluded it was uncertain if "i.v. lidocaine, when compared to placebo or no treatment, has a beneficial impact on pain scores in the early postoperative phase, and on gastrointestinal recovery, postoperative nausea, and opioid consumption".The systematic reviews drew on a limited pool of small primary studies, and even taken together, the data are rather sparse[71,72]. They are similar, though, where they reflect the primary trials that they include, as patients who might be expected to be at greater risk of postoperative pain (those already taking analgesics or experiencing longterm pain) were not included.…”
mentioning
confidence: 99%
“…This means that there was a conversion bias involved in the pooled results in this meta-analysis. Fourth, trial sequential analysis [ 50 ] could be utilized to examine the reliability of the results of this meta-analysis with a small sample size. Sixth, weighting bias may occur due to some small trials given disproportionately large weights.…”
Section: Discussionmentioning
confidence: 99%